AMY CLARK HESSEL to Ipilimumab
This is a "connection" page, showing publications AMY CLARK HESSEL has written about Ipilimumab.
Connection Strength
0.112
-
Neoadjuvant immune checkpoint blockade in high-risk resectable melanoma. Nat Med. 2018 11; 24(11):1649-1654.
Score: 0.112
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.